Cargando…

Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment

Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-N...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yandong, Gao, Fucheng, Li, Xiaofeng, Niu, Guiming, Yang, Yufei, Li, Hui, Jiang, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817594/
https://www.ncbi.nlm.nih.gov/pubmed/35123493
http://dx.doi.org/10.1186/s12951-022-01278-z
_version_ 1784645680412753920
author Wang, Yandong
Gao, Fucheng
Li, Xiaofeng
Niu, Guiming
Yang, Yufei
Li, Hui
Jiang, Yanyan
author_facet Wang, Yandong
Gao, Fucheng
Li, Xiaofeng
Niu, Guiming
Yang, Yufei
Li, Hui
Jiang, Yanyan
author_sort Wang, Yandong
collection PubMed
description Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-NCs) directly determines the anticancer effect of CDT. To learn more about this new type of therapy, this review summarizes the recent development of F-NCs that are responsive to tumor microenvironment (TME), and detailedly introduces their material design and action mechanism. Based on the deficiencies of them, some effective strategies to significantly improve the anticancer efficacy of F-NCs are highlighted, which mainly includes increasing the temperature and hydrogen peroxide concentration, reducing the pH, glutathione (GSH) content, and the dependence of F-NCs on acidic environment in the TME. It also discusses the differences between the effect of multi-mode therapy with external energy (light and ultrasound) and the single-mode therapy of CDT. Finally, the challenges encountered in the treatment process, the future development direction of F-NCs, and some suggestions are analyzed to promote CDT to enter the clinical stage in the near future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01278-z.
format Online
Article
Text
id pubmed-8817594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88175942022-02-07 Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment Wang, Yandong Gao, Fucheng Li, Xiaofeng Niu, Guiming Yang, Yufei Li, Hui Jiang, Yanyan J Nanobiotechnology Review Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-NCs) directly determines the anticancer effect of CDT. To learn more about this new type of therapy, this review summarizes the recent development of F-NCs that are responsive to tumor microenvironment (TME), and detailedly introduces their material design and action mechanism. Based on the deficiencies of them, some effective strategies to significantly improve the anticancer efficacy of F-NCs are highlighted, which mainly includes increasing the temperature and hydrogen peroxide concentration, reducing the pH, glutathione (GSH) content, and the dependence of F-NCs on acidic environment in the TME. It also discusses the differences between the effect of multi-mode therapy with external energy (light and ultrasound) and the single-mode therapy of CDT. Finally, the challenges encountered in the treatment process, the future development direction of F-NCs, and some suggestions are analyzed to promote CDT to enter the clinical stage in the near future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01278-z. BioMed Central 2022-02-05 /pmc/articles/PMC8817594/ /pubmed/35123493 http://dx.doi.org/10.1186/s12951-022-01278-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Wang, Yandong
Gao, Fucheng
Li, Xiaofeng
Niu, Guiming
Yang, Yufei
Li, Hui
Jiang, Yanyan
Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title_full Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title_fullStr Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title_full_unstemmed Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title_short Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
title_sort tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817594/
https://www.ncbi.nlm.nih.gov/pubmed/35123493
http://dx.doi.org/10.1186/s12951-022-01278-z
work_keys_str_mv AT wangyandong tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT gaofucheng tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT lixiaofeng tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT niuguiming tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT yangyufei tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT lihui tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment
AT jiangyanyan tumormicroenvironmentresponsivefentonnanocatalystsforintensifiedanticancertreatment